KW
GILD icon

Keyvantage Wealth’s Gilead Sciences GILD Stock Holding History

Keyvantage Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$812K Buy
5,826
+554
+11% +$77.6K 0.36% 43
2025
Q4 		$647K Sell
5,272
-49
-0.9% -$5.96K 0.28% 54
2025
Q3 		$591K Sell
5,321
-240
-4% -$27.3K 0.25% 55
2025
Q2 		$617K Sell
5,561
-75
-1% -$7.98K 0.28% 51
2025
Q1 		$631K Sell
5,636
-884
-14% -$91.2K 0.31% 48
2024
Q4 		$602K Buy
+6,520
New +$587K 0.43% 40

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Keyvantage Wealth's GILD Position: Q1 2026 in Review

Keyvantage Wealth increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $77.6K and bringing the position to 5,826 shares worth $812K. The position accounts for 0.36% of the portfolio, ranked #43.

Keyvantage Wealth first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Keyvantage Wealth held 5,826 shares of Gilead Sciences worth $812K as of Q1 2026.
  • Keyvantage Wealth bought 554 Gilead Sciences shares in Q1 2026, an estimated $77.6K.
  • Gilead Sciences made up 0.36% of Keyvantage Wealth's portfolio in Q1 2026, its #43 holding.
  • Keyvantage Wealth first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Keyvantage Wealth's 13F filing for Q1 2026, filed 5 May 2026.